hypericin has been researched along with rottlerin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Chen, X; Ding, HF; Lang, L; Liu, G; Sun, SY; Yan, C | 1 |
Horvath, D; Huntosova, V; Miskovsky, P; Misuth, M | 1 |
3 other study(ies) available for hypericin and rottlerin
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
Topics: CRISPR-Cas Systems; Gene Targeting; Genes; Genes, Reporter; Genetic Engineering; Humans; Internal Ribosome Entry Sites; Transcription, Genetic | 2015 |
Synergism between PKCĪ“ regulators hypericin and rottlerin enhances apoptosis in U87 MG glioma cells after light stimulation.
Topics: Acetophenones; Angiogenesis Inhibitors; Anthracenes; Antineoplastic Agents; Apoptosis; Benzopyrans; Cell Line, Tumor; Cell Survival; Gene Expression Regulation; Glioma; Humans; Light; Perylene; Photochemotherapy; Protein Kinase C-delta; Radiation-Sensitizing Agents | 2017 |